SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-15-156831
Filing Date
2015-04-29
Accepted
2015-04-29 16:53:44
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM 424(B)(3) PROSPECTUS d770501d424b4.htm 424B4 1415529
2 GRAPHIC g770501g06s19.jpg GRAPHIC 39265
3 GRAPHIC g770501g25h47.jpg GRAPHIC 71583
4 GRAPHIC g770501g34o77.jpg GRAPHIC 82180
5 GRAPHIC g770501g43n04.jpg GRAPHIC 82894
6 GRAPHIC g770501g45f49.jpg GRAPHIC 57784
7 GRAPHIC g770501g57e02.jpg GRAPHIC 45615
8 GRAPHIC g770501g68m32.jpg GRAPHIC 15066
9 GRAPHIC g770501g99i00.jpg GRAPHIC 71583
  Complete submission text file 0001193125-15-156831.txt   2059709
Mailing Address 11119 NORTH TORREY PINES ROAD, SUITE 50 SAN DIEGO CA 92037
Business Address 11119 NORTH TORREY PINES ROAD, SUITE 50 SAN DIEGO CA 92037 858-550-7810
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-197182 | Film No.: 15813569
SIC: 2834 Pharmaceutical Preparations